.Merck trumps incomes expectations, rears sales expectation on strong need for top drugs like Keytruda CNBCMerck & Co. (MRK United States) Beats Earnings Forecasts as Keytruda Purchases Increase BloombergMerck Inventory: Pharma Titan Posts Sturdy End Results, But Outlook Falls Short Financier's Company DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats earnings and sales requirements surrounded by Keytruda strength, however supplies blended full-year overview MarketWatch.